Travere Therapeutics
TVTX
$5.46
Share price
3.80%
Change (1 day)
-75.85%
Change (1 year)
Categories
Travere Therapeutics (TVTX) - Cash on Hand
Cash on Hand as of December 2023 : $0.56 B
According to Travere Therapeutics's latest financial reports the company has $0.56 B in cash and cash equivalents.
A company’s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Travere Therapeutics - Cash on Hand chart (from 2011 to 2023)
Cash on Hand by year
| Year | Cash on Hand | Change |
|---|---|---|
| 2023-12-31 | $0.56 B | 25.9% |
| 2022-12-31 | $0.45 B | -18.56% |
| 2021-12-31 | $0.55 B | 52.9% |
| 2020-12-31 | $0.36 B | -9.27% |
| 2019-12-31 | $0.39 B | -15.48% |
| 2018-12-31 | $0.47 B | 56.85% |
| 2017-12-31 | $0.30 B | 17.49% |
| 2016-12-31 | $0.25 B | 11.44% |
| 2015-12-31 | $0.22 B | 727.1% |
| 2014-12-31 | $27.76 M | 352.83% |
| 2013-12-31 | $6.13 M | 53731.23% |
| 2012-12-31 | $0.01 M | |
| 2012-02-29 | $0 M | |
| 2011-02-28 | $0 M |
Cash on Hand for similar companies or competitors
| Company | Cash on Hand | differencediff. | Country |
|---|---|---|---|
 OPKO Health
OPK | $95.88 M | -83.09% | 🇺🇸 USA |
 Onconova Therapeutics ONTX | $20.82 M | -96.33% | 🇺🇸 USA |